| Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds M Yazdanian, SL Glynn, JL Wright, A Hawi Pharmaceutical research 15 (9), 1490, 1998 | 555 | 1998 |
| The “high solubility” definition of the current FDA guidance on biopharmaceutical classification system may be too strict for acidic drugs M Yazdanian, K Briggs, C Jankovsky, A Hawi Pharmaceutical research 21, 293-299, 2004 | 388 | 2004 |
| Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery KA Foster, ML Avery, M Yazdanian, KL Audus International journal of pharmaceutics 208 (1-2), 1-11, 2000 | 331 | 2000 |
| Microparticulate uptake mechanisms of in‐vitro cell culture models of the respiratory epithelium KA Foster, M Yazdanian, KL Audus Journal of pharmacy and pharmacology 53 (1), 57-66, 2001 | 226 | 2001 |
| In vitro blood–brain barrier permeability of nevirapine compared to other HIV antiretroviral agents SL Glynn, M Yazdanian Journal of pharmaceutical sciences 87 (3), 306-310, 1998 | 187 | 1998 |
| Ionic interactions of fatty acid monolayers at the air/water interface M Yazdanian, H Yu, G Zografi Langmuir 6 (6), 1093-1098, 1990 | 150 | 1990 |
| A structure–permeability study of small drug-like molecules T Fichert, M Yazdanian, JR Proudfoot Bioorganic & medicinal chemistry letters 13 (4), 719-722, 2003 | 121 | 2003 |
| Evolution of choice of solubility and dissolution media after two decades of biopharmaceutical classification system N Bou-Chacra, KJC Melo, IAC Morales, ES Stippler, F Kesisoglou, ... The AAPS journal 19, 989-1001, 2017 | 116 | 2017 |
| Evaluation of an accelerated Caco‐2 cell permeability model E Liang, K Chessic, M Yazdanian Journal of pharmaceutical sciences 89 (3), 336-345, 2000 | 115 | 2000 |
| P-glycoprotein efflux pump expression and activity in Calu-3 cells KO Hamilton, G Backstrom, MA Yazdanian, KL Audus Journal of pharmaceutical sciences 90 (5), 647-658, 2001 | 112 | 2001 |
| Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers E Liang, J Proudfoot, M Yazdanian Pharmaceutical research 17, 1168-1174, 2000 | 108 | 2000 |
| An ellipsometric study of polymer monolayers at the air/water interface BB Sauer, H Yu, M Yazdanian, G Zografi, MW Kim Macromolecules 22 (5), 2332-2337, 1989 | 101 | 1989 |
| Multidrug resistance-associated protein-1 functional activity in Calu-3 cells KO Hamilton, E Topp, I Makagiansar, T Siahaan, M Yazdanian, KL Audus Journal of Pharmacology and Experimental Therapeutics 298 (3), 1199-1205, 2001 | 98 | 2001 |
| Modulation of P-glycoprotein activity in Calu-3 cells using steroids and β-ligands KO Hamilton, MA Yazdanian, KL Audus International journal of pharmaceutics 228 (1-2), 171-179, 2001 | 85 | 2001 |
| Discovery and Characterization of 6-{4-[3-(R)-2-Methylpyrrolidin-1-yl) propoxy] phenyl}-2 H-pyridazin-3-one (CEP-26401, Irdabisant): A Potent, Selective Histamine H3 Receptor … RL Hudkins, R Raddatz, M Tao, JR Mathiasen, LD Aimone, NC Becknell, ... Journal of medicinal chemistry 54 (13), 4781-4792, 2011 | 80 | 2011 |
| The effect of excipients on the permeability of BCS Class III compounds and implications for biowaivers A Parr, IJ Hidalgo, C Bode, W Brown, M Yazdanian, MA Gonzalez, ... Pharmaceutical research 33, 167-176, 2016 | 71 | 2016 |
| Divalent cation-stearic acid monolayer interactions at the air/water interface M Yazdanian, H Yu, G Zografi, MW Kim Langmuir 8 (2), 630-636, 1992 | 61 | 1992 |
| Is PAMPA a useful tool for discovery? D Galinis‐Luciani, L Nguyen, M Yazdanian Journal of pharmaceutical sciences 96 (11), 2886-2892, 2007 | 57 | 2007 |
| CEP-32496: a novel orally active BRAFV600E inhibitor with selective cellular and in vivo antitumor activity J James, B Ruggeri, RC Armstrong, MW Rowbottom, S Jones-Bolin, ... Molecular cancer therapeutics 11 (4), 930-941, 2012 | 54 | 2012 |
| Permeability measurement of macromolecules and assessment of mucosal antigen sampling using in vitro converted M cells E Liang, AK Kabcenell, JR Coleman, J Robson, R Ruffles, M Yazdanian Journal of pharmacological and toxicological methods 46 (2), 93-101, 2001 | 49 | 2001 |
